Entries by mercuric

EUPATI Summer 2016 Newsletter

The summer 2016 newsletter for the European Patients’ Academy (EUPATI) is now available. In this issue, you can access the Patient Expert Training Course, now available in English, as well as learn about the growing national EUPATI teams that function as patient involvement groups locally.

MErCuRIC members serving the interests of upcoming young talents in oncology – the future of our profession

While the ever-advancing landscape of precision medicine in oncology undoubtedly brings fresh hope for patients, it also poses many yet unanswered questions as to how we move forward, without the real risk of burn-out of those who treat them – particularly with regards to the up-and- coming generation of young oncologists, the future of our profession and practice. Established […]

Delivering 21st Century Medicine for bowel cancer patients

In June 2016, the Northern Ireland Cancer Research Consumer Forum and its Bowel Cancer Research Interest Group hosted a public event – ‘Delivering 21st Century Medicine for bowel cancer patients’. A MErCuRIC poster was displayed at the event in Belfast. The event was opened by a member of the Local Assembly and speakers included MErCuRIC researcher […]

ASCO 2016 Meeting

MErCuRIC researchers from RCSI, BHSCT, QUB and PDUM presented results from their other research projects in colorectal cancer at the American Society of Clinical Oncology (ASCO) 2016 Annual meeting in Chicago, 03 – 07 June. A systems model of BCL-2 dependent apoptosis to predict stage II CRC patients benefiting from adjuvant chemotherapy and as a […]

Public Event on Bowel Cancer in Belfast

On 29 June 2016, MErCuRIC partners from BHSCT and QUB will participate in a free public event on bowel cancer. Prof. Mark Lawler (QUB) will speak at the event, which will include patients, advocates and researchers as attendees.

Posters at AACR Annual Meeting

‘Validation of a MEK/MET-specific NGS panel for early phase trial interrogation‘ and ‘Upregulation of the MET transcript is consistently associated with invasion and tumor budding in colorectal cancer‘ were presented at the AACR Annual Meeting on 18 Apr 2016 in New Orleans. Mariangela Russo from UNITO also presented related work (Abstract 878).   Validation of a MEK/MET-specific […]

Colorectal Cancer Information Day in Paris

MErCuRIC partner hospital Hôpital Georges-Pompidou is hosting a Colorectal Cancer Information Day, open to the public on Tuesday 09 March. The event will include a simulation on the Da Vinci surgical robot and a Giant Colon to see what your own gut looks like! Registration is required at 01 56 09 39 82 or contact.hegp@egp.aphp.fr    

EUPATI Toolbox Launched

EUPATI (European Patients‘ Academy on Therapeutic Innovation) launched the EUPATI Toolbox today. Funded by the Innovative Medicines Initiative, EUPATI provides scientifically reliable, objective, comprehensive information to patients on medicines research and development. The Toolbox covers the A to Z of how medicines are developed. Check it out here!

MErCuRIC Year 2 Meeting

MErCuRIC partners attended a successful meeting in Dublin, Ireland on 15 Jan 2016. Progress made by the consortium in year 2 was discussed and work for year 3 was planned. Our first Phase I study is drawing to a close and plans for the next Phase I work are well underway. We have also advanced the […]